Zobrazeno 1 - 10 of 1 099 pro vyhledávání: '"Granados-Principal S"'
2
Akademický článek
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy.
Autor: Blaya-Cánovas JL; UGC de Oncología Médica, Hospital Universitario de Jaén, Jaén, 23007, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain., Griñán-Lisón C; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain.; Department of Biochemistry and Molecular Biology 2, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada, 18071, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, 18100, Spain., Blancas I; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; UGC de Oncología, Hospital Universitario San Cecilio, Granada, 18016, Spain.; Department of Medicine, University of Granada, Granada, 18016, Spain., Marchal JA; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, 18100, Spain.; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research, (CIBM), University of Granada, Granada, 18100, Spain.; Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, 18016, Spain., Ramírez-Tortosa C; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; UGC de Anatomía Patológica, Hospital San Cecilio, Granada, 18016, Spain., López-Tejada A; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain.; Department of Biochemistry and Molecular Biology 2, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada, 18071, Spain., Benabdellah K; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain., Cortijo-Gutiérrez M; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain., Cano-Cortés MV; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain.; Department of Medicinal & Organic Chemistry and Excellence Research Unit of 'Chemistry Applied to Biomedicine and the Environment', Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada, 18071, Spain., Graván P; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, 18100, Spain.; Department of Applied Physics, Faculty of Science, University of Granada, Granada, 18071, Spain., Navarro-Marchal SA; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, 18100, Spain.; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research, (CIBM), University of Granada, Granada, 18100, Spain.; Department of Applied Physics, Faculty of Science, University of Granada, Granada, 18071, Spain., Gómez-Morales J; Laboratorio de Estudios Cristalográficos IACT-CSIC-UGR, Armilla, 18100, Spain., Delgado-Almenta V; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain., Calahorra J; UGC de Oncología Médica, Hospital Universitario de Jaén, Jaén, 23007, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain., Agudo-Lera M; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain., Sagarzazu A; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain., Rodríguez-González CJ; UGC de Oncología, Hospital Universitario San Cecilio, Granada, 18016, Spain., Gallart-Aragón T; Department of Medicine, University of Granada, Granada, 18016, Spain.; UGC de Cirugía General y del Aparato Digestivo, Hospital Universitario San Cecilio, Granada, 18016, Spain., Eich C; Translational Nanobiomaterials and Imaging, Department of Radiology, Leiden University Medical Center, Leiden, 2333, The Netherlands., Sánchez-Martín RM; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain.; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain.; Department of Medicinal & Organic Chemistry and Excellence Research Unit of 'Chemistry Applied to Biomedicine and the Environment', Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada, 18071, Spain., Granados-Principal S; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada- University of Granada, Granada, 18100, Spain. sergiogp@ugr.es.; Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, Granada, 18016, Spain. sergiogp@ugr.es.; Department of Biochemistry and Molecular Biology 2, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada, 18071, Spain. sergiogp@ugr.es.
Publikováno v: Molecular cancer [Mol Cancer] 2024 May 09; Vol. 23 (1), pp. 83. Date of Electronic Publication: 2024 May 09.
Zobrazit plný text záznamu
3
Akademický článek
Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells.
Autor: Calahorra J; UGC de Oncología Médica, Hospital Universitario de Jaén, Jaén 23007, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Granada 18100, Spain; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain. Electronic address: jesus.calahorra.gm@gmail.com., Blaya-Cánovas JL; UGC de Oncología Médica, Hospital Universitario de Jaén, Jaén 23007, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Granada 18100, Spain; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain., Castellini-Pérez O; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain., Aparicio-Puerta E; Clinical Bioinformatics, Center for Bioinformatics, Saarland University, Saarbrücken 66123, Germany., Cives-Losada C; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, Salamanca 37007, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid 28029, Spain., Marin JJG; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, Salamanca 37007, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid 28029, Spain., Rementeria M; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain., Cara FE; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Granada 18100, Spain., López-Tejada A; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Granada 18100, Spain; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain; Department of Biochemistry and Molecular Biology 2, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada 18071, Spain., Griñán-Lisón C; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Granada 18100, Spain; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain; Department of Biochemistry and Molecular Biology 2, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada 18071, Spain., Aulicino F; BrisSynBio Bristol Synthetic Biology Centre, Biomedical Sciences, School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK., Berger I; BrisSynBio Bristol Synthetic Biology Centre, Biomedical Sciences, School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK; Max Planck Bristol Centre for Minimal Biology, School of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, UK., Marchal JA; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Granada 18100, Spain., Delgado-Almenta V; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain., Granados-Principal S; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Granada 18100, Spain; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain; Department of Biochemistry and Molecular Biology 2, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada 18071, Spain. Electronic address: sergiogp@ugr.es.
Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 May; Vol. 174, pp. 116439. Date of Electronic Publication: 2024 Mar 21.
Zobrazit plný text záznamu
4
Akademický článek
Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
Autor: Cruz-Lozano M; UGC de Oncología Médica, Complejo Hospitalario de Jaén, Avenida del Ejército Español 10, Jaén, Spain.; GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada -Avenida de la Ilustración, 114-18016, Granada, Spain., González-González A; UGC de Oncología Médica, Complejo Hospitalario de Jaén, Avenida del Ejército Español 10, Jaén, Spain.; GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada -Avenida de la Ilustración, 114-18016, Granada, Spain., Marchal JA; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Universidad de Granada, Granada, Spain.; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, Granada, Spain., Muñoz-Muela E; UGC de Oncología Médica, Complejo Hospitalario de Jaén, Avenida del Ejército Español 10, Jaén, Spain.; GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada -Avenida de la Ilustración, 114-18016, Granada, Spain., Molina MP; UGC de Oncología Médica, Complejo Hospitalario de Jaén, Avenida del Ejército Español 10, Jaén, Spain.; GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada -Avenida de la Ilustración, 114-18016, Granada, Spain., Cara FE; UGC de Oncología Médica, Complejo Hospitalario de Jaén, Avenida del Ejército Español 10, Jaén, Spain.; GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada -Avenida de la Ilustración, 114-18016, Granada, Spain., Brown AM; Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, USA., García-Rivas G; Centro de Investigación Biomédica, Hospital Zambrano Hellion, Tecnológico de Monterrey, Monterrey, NL, Mexico., Hernández-Brenes C; Centro de Investigación Biomédica, Hospital Zambrano Hellion, Tecnológico de Monterrey, Monterrey, NL, Mexico., Lorente JA; GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada -Avenida de la Ilustración, 114-18016, Granada, Spain., Sanchez-Rovira P; UGC de Oncología Médica, Complejo Hospitalario de Jaén, Avenida del Ejército Español 10, Jaén, Spain.; GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada -Avenida de la Ilustración, 114-18016, Granada, Spain., Chang JC; Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, TX, USA., Granados-Principal S; UGC de Oncología Médica, Complejo Hospitalario de Jaén, Avenida del Ejército Español 10, Jaén, Spain. sergio.granados.exts@juntadeandalucia.es.; GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada -Avenida de la Ilustración, 114-18016, Granada, Spain. sergio.granados.exts@juntadeandalucia.es.
Publikováno v: European journal of nutrition [Eur J Nutr] 2019 Dec; Vol. 58 (8), pp. 3207-3219. Date of Electronic Publication: 2018 Nov 21.
Zobrazit plný text záznamu
5
Akademický článek
TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression.
Autor: López-Tejada A; Department of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, 18011 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain., Griñán-Lisón C; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain.; UGC de Oncología Médica, Hospital Universitario de Jaén, 23007 Jaén, Spain., González-González A; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Cara FE; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Luque RJ; UGC de Anatomía Patológica, Hospital Universitario de Jaén, Jaén, Spain., Rosa-Garrido C; FIBAO, Hospital Universitario de Jaén, Servicio Andaluz de Salud, Jaén, Spain., Blaya-Cánovas JL; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain.; UGC de Oncología Médica, Hospital Universitario de Jaén, 23007 Jaén, Spain., Navarro-Ocón A; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain., Valenzuela-Torres M; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Parra-López M; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Calahorra J; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain.; UGC de Oncología Médica, Hospital Universitario de Jaén, 23007 Jaén, Spain., Blancas I; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain.; UGC de Oncología, Hospital Universitario 'San Cecilio', 18016 Granada, Spain., Marchal JA; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain.; Department of Human Anatomy and Embryology, Biopathology and Regenerative Medicine Institute (IBIMER), University of Granada, 18011 Granada, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Spain., Granados-Principal S; Department of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, 18011 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain.
Publikováno v: International journal of biological sciences [Int J Biol Sci] 2023 Jan 01; Vol. 19 (1), pp. 204-224. Date of Electronic Publication: 2023 Jan 01 (Print Publication: 2023).
Zobrazit plný text záznamu
6
Akademický článek
EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization.
Autor: Gallardo A; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain., Molina A; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain., Asenjo HG; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain., Lopez-Onieva L; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain., Martorell-Marugán J; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Department of Statistics, Faculty of Sciences, University of Granada, Granada, Spain.; Data Science for Health Research Unit, Fondazione Bruno Kessler, Trento, Italy., Espinosa-Martinez M; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain., Griñan-Lison C; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; UGC de Oncología Médica, Complejo Hospitalario de Jaen, 23007, Jaen, Spain., Alvarez-Perez JC; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain., Cara FE; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain., Navarro-Marchal SA; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Department of Applied Physics, Faculty of Science, University of Granada, 18071, Granada, Spain.; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, 18016, Granada, Spain.; Excellence Research Unit Modelling Nature (MNat), University of Granada, 18016, Granada, Spain.; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU, Edinburgh, UK., Carmona-Sáez P; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Department of Statistics, Faculty of Sciences, University of Granada, Granada, Spain., Medina PP; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain., Marchal JA; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, 18016, Granada, Spain.; Excellence Research Unit Modelling Nature (MNat), University of Granada, 18016, Granada, Spain.; Department of Human Anatomy and Embryology, School of Medicine, University of Granada, Granada, Spain., Granados-Principal S; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain., Sánchez-Pozo A; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain.; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain., Landeira D; Centre for Genomics and Oncological Research (GENYO), Avenida de la Ilustración 114, 18016, Granada, Spain. davidlandeira@ugr.es.; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain. davidlandeira@ugr.es.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain. davidlandeira@ugr.es.
Publikováno v: Oncogene [Oncogene] 2022 Jul; Vol. 41 (28), pp. 3611-3624. Date of Electronic Publication: 2022 Jun 09.
Zobrazit plný text záznamu
7
Akademický článek
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer.
Autor: Navarro-Ocón A; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain., Blaya-Cánovas JL; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; UGC de Oncología Médica, Complejo Hospitalario de Jaen, 23007 Jaen, Spain., López-Tejada A; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, 18011 Granada, Spain., Blancas I; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; UGC de Oncología, Hospital Universitario 'San Cecilio', 18016 Granada, Spain., Sánchez-Martín RM; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain., Garrido MJ; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy & Nutrition, Navarra Institute for Health Research (IdisNA), University of Navarra, 31080 Pamplona, Spain., Griñán-Lisón C; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; UGC de Oncología Médica, Complejo Hospitalario de Jaen, 23007 Jaen, Spain., Calahorra J; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; UGC de Oncología Médica, Complejo Hospitalario de Jaen, 23007 Jaen, Spain., Cara FE; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain., Ruiz-Cabello F; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Biochemistry, Molecular Biology 3 and Immunology, School of Medicine, University of Granada, 18071 Granada, Spain., Marchal JA; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Human Anatomy and Embryology, School of Medicine, University of Granada, 18016 Granada, Spain., Aptsiauri N; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Biochemistry, Molecular Biology 3 and Immunology, School of Medicine, University of Granada, 18071 Granada, Spain., Granados-Principal S; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, 18011 Granada, Spain.
Publikováno v: Pharmaceutics [Pharmaceutics] 2022 Feb 25; Vol. 14 (3). Date of Electronic Publication: 2022 Feb 25.
Zobrazit plný text záznamu
8
Resistance to targeted therapies in renal cancer: the importance of changing the mechanism of action - pubmed
Autor: Duran, I, Lambea, J, Maroto, P, González-Larriba, J L, Flores, Luis, Granados-Principal, S, Graupera, M, Sáez, B, Vivancos, A, Casanovas, O
Renal cell carcinoma (RCC) is a complex disease characterized by mutations in several genes. Loss of function of the von Hippel-Lindau (VHL) tumour suppressor gene is a very common finding in RCC and leads to up-regulation of hypoxia-inducible factor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2659::93e021960c4534858d245f7a95e5c200
https://zenodo.org/record/4153932
Zobrazit plný text záznamu
9
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
Autor: Duran, I, Lambea, J, Maroto, P, Gonzalez-Larriba, JL, Flores, L, Granados-Principal, S, Graupera, M, Saez, B, Vivancos, A, Casanovas, O
Publikováno v: Targeted Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Renal cell carcinoma (RCC) is a complex disease characterized by mutations in several genes. Loss of function of the von Hippel-Lindau (VHL) tumour suppressor gene is a very common finding in RCC and leads to up-regulation of hypoxia-inducible factor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::258b7b547eddf4f5b4834cd614f29ef9
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6671
Zobrazit plný text záznamu
10
Akademický článek
Radioprotective potential of pomegranate peel extract against gamma irradiation-induced hazards.
Autor: Hamieda, Shimaa Farag1 (AUTHOR), Saied, Mona1 (AUTHOR), Abd-El-Nour, K. N.1 (AUTHOR), Hassan, Amal I.2 (AUTHOR) virtualaml@gmail.com
Publikováno v: Bulletin of the National Research Centre. 10/14/2024, Vol. 48 Issue 1, p1-12. 12p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje